SEND Blog

BiotechCompany NewsCROData IntegrationPharmaceuticalPre-ClinicalRegulatory SubmissionSENDSEND Advantage ServicesToxicology

Instem Team

February 26, 2025

The Past, Present, and Future of SEND: The Continuing Evolution of Our Nonclinical Standard

BiotechCROPharmaceuticalPre-ClinicalRegulatory ComplianceRegulatory SubmissionRegulatory SubmissionsSENDSEND Advantage ServicesToxicology

Instem Team

February 25, 2025

Preparing your regulatory team for the new SENDIG-GeneTox requirements.

BiotechCROPharmaceuticalPre-ClinicalRegulatory SubmissionRegulatory SubmissionsSENDSEND Advantage ServicesSensible SENDSubmit

Marc Ellison

January 6, 2025

Read the latest from our Sensible SEND blog.

BiotechCROPharmaceuticalPre-ClinicalRegulatory SubmissionRegulatory SubmissionsSENDSEND Advantage ServicesSensible SENDSubmit

Marc Ellison

December 17, 2024

Read the latest blog from Marc Ellison, Director, SEND Solutions, Instem.

AdvanceCentrusPre-ClinicalRegulatory SubmissionsResourcesSENDSEND Advantage Services

Instem Team

December 16, 2024

Watch this 40-minute presentation to learn more about Weight of Evidence approaches and the use of SEND datasets

BiotechCROPharmaceuticalPre-ClinicalRegulatory ComplianceRegulatory SubmissionRegulatory SubmissionsSENDSEND Advantage ServicesSubmit

Mike Thurogood, CMktr

December 5, 2024

Meet Marc Ellison, Director, SEND Solutions, Instem.

Stay up to Date

Get expert tips, industry news, and fresh content delivered to your inbox.